Business
Press Release May 30 2026
Wockhardt Limited has informed the Exchange regarding a press release dated May 29, 2026, titled " Wockhardt Receives U.S. FDA Approval for ZAYNICH (cefepime and zidebactam), a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including Pyelonephritis.
About this update from Wockhardt Limited
Wockhardt Limited has informed the Exchange regarding a press release dated May 29, 2026, titled " Wockhardt Receives U.S. FDA Approval for ZAYNICH (cefepime and zidebactam), a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including Pyelonephritis. View Attachment